US equities |
MU $1,035.84 ▲+0.00% SPCX $160.57 ▲+0.00% NVDA $230.48 ▲+0.00% AAPL $340.42 ▲+0.00% SNDK $1,609.46 ▲+0.00% INTC $107.08 ▲+0.00% AMD $620.68 ▲+0.00% LITE $1,048.60 ▲+0.00%
FinancialContent

Latest News about Cedar Clinical Research

Recent news which mentions Cedar Clinical Research

Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
Tickers CMPS MNMD NUMIF
Tags CMPS Small Cap Cedar Clinical Research
From Benzinga
Numinus Q2 2023: 581% Revenue Growth, 820% In Gross Profit And Strong Cash Position
Tickers NUMIF
Tags Cannabis Cedar Clinical Research financial results
From Benzinga